Stock report · Delisted · Nasdaq

GoHealth, Inc. (GOCO)

0.34USD Delisted Final close · Jun 17, 2026

GOCO no longer trades. GoHealth filed prepackaged Chapter 11 cases on June 7, 2026, and Nasdaq suspended trading in its Class A common stock on June 16, 2026. The shares moved to the over-the-counter market under GOCOQ.

All prices on this page are historical. The last trade was on June 17, 2026, at $0.34.

GOCO stock price history

Loading chart…
Split-adjusted closing prices, 2020–2026

Final trading statistics

Final close
$0.34
Final trading day
Jun 17, 2026
Market cap at delisting
$5.59M
Shares outstanding
16.69M
Final 52-week range
$0.27 – $7.12
Avg. volume (final 3 mo.)
359,462
All-time high
$329.70 · Jul 2020
All-time low
$0.29 · Jun 2026
Return since IPO
-99.9%
Beta
1.17
Book value / share
$0.13
Price / book
2.56

About GoHealth, Inc.

GoHealth, Inc. operated a health insurance marketplace focused mainly on Medicare, headquartered in Chicago, Illinois. The business was founded in 2001 and connected consumers with plans from a range of insurance carriers through a technology platform and a large force of licensed agents. It had additional offices in Charlotte, North Carolina, Lindon, Utah, and in Slovakia.

Its products included Medicare Advantage, Medicare Supplement, prescription drug plans and Special Needs Plans, as well as Individual and Family Plans, dental, vision and other ancillary coverage. The company reported results in segments covering its internal and external Medicare business and its individual and family plan and other business. Revenue came largely as commissions paid by carriers when consumers enrolled in a policy and as those policies stayed in force.

GoHealth completed its initial public offering in July 2020 and listed Class A common stock on the Nasdaq Global Select Market under the symbol GOCO. It used an Up-C structure, in which the public company held an interest in GoHealth Holdings, LLC alongside other unit holders. Private equity investors including Centerbridge and Francisco Partners had been significant owners before the offering.

After the IPO, the business faced pressure from changes in the Medicare Advantage market, high costs of acquiring and retaining customers, and a heavy debt load. The company's market value declined substantially. On March 18, 2026, Nasdaq notified GoHealth that it had fallen below the minimum market value of listed securities requirement of $35 million.

On June 7, 2026, GoHealth, Inc., GoHealth Holdings, LLC and certain subsidiaries filed voluntary Chapter 11 petitions in the U.S. Bankruptcy Court for the District of Delaware to carry out a prepackaged plan of reorganization. Under the plan, existing equity interests other than the Series A redeemable convertible preferred stock would be cancelled, holders of Class A common stock and Holdings units would receive only a limited recovery, and control of the reorganized company would likely change.

On June 9, 2026, Nasdaq informed the company that it would delist the Class A common stock, citing the bankruptcy filing, concerns about the residual equity interest of current security holders, and doubts about the company's ability to meet continued listing requirements, along with the earlier market value deficiency. GoHealth said it did not intend to appeal.

Trading on Nasdaq was suspended at the opening of business on June 16, 2026, and a Form 25-NSE was filed with the SEC in July. The shares became quoted over the counter under the symbol GOCOQ. The company said the delisting would not affect its operations or the Chapter 11 cases.

Exchange (former)
Nasdaq
Sector
Financial Services
Industry
Insurance Brokers
Headquarters
Chicago, IL
Employees
850
IPO date
July 15, 2020
Delisted
June 17, 2026
SEC CIK
1808220

GoHealth financials before the delisting

The last 5 fiscal years GoHealth reported as a public company, fiscal year ending December.

GOCO revenue and net income

RevenueNet income

GOCO earnings per share

Earnings per share

GOCO annual financials

GoHealth, Inc. revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$361.85M−$257.1M−$18.45
FY2024$798.89M−$2.9M−$1.29
FY2023$734.67M−$63.3M−$7.22
FY2022$631.67M−$148.7M−$14.35
FY2021$1.06B−$189.4M$25.35

Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.

GoHealth stock FAQ

What happened to GoHealth stock?

GoHealth filed prepackaged Chapter 11 cases on June 7, 2026, and Nasdaq suspended trading in its Class A common stock on June 16, 2026. The shares moved to the over-the-counter market under GOCOQ. The final close was $0.34 on June 17, 2026.

Can I still buy GOCO stock?

No. GOCO is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on June 17, 2026.

What was the last price of GOCO?

GOCO last closed at $0.34 on June 17, 2026, which valued the company at about $5.59M.

How did GoHealth do in its last full fiscal year?

In fiscal 2025, its last full year as a public company, GoHealth reported revenue of $361.85M and net income of −$257.1M.

When did GoHealth go public?

GoHealth shares started trading on July 15, 2020.

GOCO no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.